Cynomolgus RANKL/OPGL/TNFSF11 (CD254) (Fc Tag) recombinant protein

Cat.#: 501572

Size:

Special Price 478.5 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Cynomolgus RANKL/OPGL/TNFSF11 (CD254) (Fc Tag) recombinant protein
  • Documents
  • Description
    Tumor necrosis factor ligand superfamily member 11, also known as Receptor activator of nuclear factor kappa-B ligand, Osteoprotegerin ligand, TNFSF11, RANKL, TRANCE, OPGL and CD254, is a single-pass type II membrane protein which belongs to the tumor necrosis factor family. The receptor activator of nuclear factor-kappaB ligand (RANKL), its cognate receptor RANK, and its natural decoy receptor osteoprotegerin have been identified as the final effector molecules of osteoclastic bone resorption. RANK and RANKL are key regulators of bone remodeling and regulate T cell/dendritic cell communications, and lymph node formation. Moreover, RANKL and RANK are expressed in mammary gland epithelial cells and control the development of a lactating mammary gland during pregnancy. Genetically, RANKL and RANK are essential for the development and activation of osteoclasts and bone loss in response to virtually all triggers tested. Inhibition of RANKL function via the natural decoy receptor osteoprotegerin (OPG, TNFRSF11B) prevents bone loss in postmenopausal osteoporosis and cancer metastases. Importantly, RANKL appears to be the pathogenetic principle that causes bone and cartilage destruction in arthritis. RANK-RANKL signaling not only activates a variety of downstream signaling pathways required for osteoclast development, but crosstalk with other signaling pathways also fine-tunes bone homeostasis both in normal physiology and disease. In addition, RANKL and RANK have essential roles in lymph node formation, establishment of the thymic microenvironment, and development of a lactating mammary gland during pregnancy.
  • Protein name
    Receptor activator of nuclear factor kappa-B ligand
  • Protein short names
    OPGL; CD254; RANKL; ODF; SODF; RP11-86N24.2; HRANKL2; LY109L; TRANCE; OPG; OPTB2; TNFSF11
  • Uniprot ID
    G7PW41
  • Gene Name
    EGM_08438
  • Source/Expression Host
    Human Cells
  • Expression Plasmid/cDNA
    A DNA sequence encoding the cynomolgus TNFSF11 (G7PW41) (Gly136-Asp317) was expressed with the Fc region of human IgG1 at the N-terminus.
  • Protein Species
    Cynomolgus
  • Molecular weight
    The recombinant cynomolgus TNFSF11 comprises 442 amino acids and has a calculated molecular mass of 48.9 KDa. The apparent molecular mass of the protein is approximately 55 KDa in SDS-PAGE.
  • Purity
    > 85 % as determined by SDS-PAGE
  • Activity
    1. Immobilized Cynomolgus S4-Fc3L3-TNFSF11 at 10 μg/ml (100 μl/well) can bind biotinylated human TNFRSF11B-His (Cat:500115), The EC50 of biotinylated human TNFRSF11B-His (Cat:500115) is 7.94-18.52 ng/ml.
    2. The bioactivity of hRANKL was determined by measuring the ability of hRANKL to induce TRAP activity in Raw 264.7 cells. The ED50 for this effect is typically 0.1-0.4 μg/mL.
  • Validations

    Cynomolgus RANKL / OPGL / TNFSF11 Protein (Fc Tag) SDS-PAGE

    Cynomolgus RANKL / OPGL / TNFSF11 Protein (Fc Tag) SDS-PAGE

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"